
- ONCOLOGY Vol 23 No 7
- Volume 23
- Issue 7
ACLU Challenges Patents on Breast Cancer Genes
The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law filed a lawsuit charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit women’s options regarding their medical care.
The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law filed a lawsuit charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit women's options regarding their medical care. Mutations along the BRCA1 and BRCA2 genes are responsible for most cases of hereditary breast and ovarian cancers. The lawsuit argues that the patents on these genes are unconstitutional and invalid.
Articles in this issue
almost 17 years ago
Low-Risk Papillary Thyroid Cancer: Treatment Options and Patient Perceptionsalmost 17 years ago
Prophylactic Central Lymph Node Dissection: Continued Controversyalmost 17 years ago
Music Therapyalmost 17 years ago
Is There a Role for LHRH Antagonists in Prostate Cancer?almost 17 years ago
Important Considerations in LHRH Antagonist Therapy for Prostate Canceralmost 17 years ago
The Role of LHRH Antagonists in the Treatment of Prostate CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


























































